CYRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cryoport Inc (CYRX) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While there are some positive catalysts, such as the recent analyst buy rating and a price target significantly above the current price, the company's weak financial performance, overbought technical indicators, and lack of strong trading signals suggest waiting for a better entry point.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 86.383, signaling that the stock is overbought. Moving averages are converging, and the stock is trading near its resistance levels (R1: 9.549, R2: 10.028), suggesting limited immediate upside potential.
The stock has also shown a 5.74% regular market gain and a 1.84% post-market gain, indicating short-term bullish sentiment.
Insider and hedge fund trading trends are neutral, and there is no recent news or congress trading activity to act as a catalyst. Additionally, the stock is overbought based on RSI, and no strong trading signals (AI Stock Picker or SwingMax) are present.
In Q4 2025, revenue increased by 9.64% YoY to $45.45M, and gross margin improved slightly to 47.77%. However, net income dropped significantly by 34.01% YoY to -$13.64M, and EPS fell by 35.71% to -$0.27, indicating declining profitability.
Craig-Hallum initiated coverage with a Buy rating and a $15 price target, highlighting the company's potential in the C> market and its underestimated growth prospects. No other recent analyst ratings or price target changes are available.
